GENinCode (LON:GENI) Stock Price Down 12.3% – What’s Next?

GENinCode Plc (LON:GENIGet Free Report)’s share price dropped 12.3% on Tuesday . The stock traded as low as GBX 2.50 ($0.03) and last traded at GBX 2.50 ($0.03). Approximately 2,380,361 shares traded hands during mid-day trading, an increase of 222% from the average daily volume of 740,144 shares. The stock had previously closed at GBX 2.85 ($0.04).

GENinCode Stock Down 2.0 %

The business’s 50 day simple moving average is GBX 3.57 and its 200-day simple moving average is GBX 4.09. The company has a debt-to-equity ratio of 9.28, a quick ratio of 15.89 and a current ratio of 2.60. The company has a market cap of £4.44 million, a price-to-earnings ratio of -0.73 and a beta of 0.66.

GENinCode Company Profile

(Get Free Report)

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies.

Further Reading

Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.